学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
Updated clinical risk factor analysis of suspected hypersensitivity reactions to abacavir
被引:75
作者
:
Cutrell, AG
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Stat & Programming, Res Triangle Pk, NC 27709 USA
GlaxoSmithKline, Stat & Programming, Res Triangle Pk, NC 27709 USA
Cutrell, AG
[
1
]
Hernandez, JE
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Stat & Programming, Res Triangle Pk, NC 27709 USA
Hernandez, JE
Fleming, JW
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Stat & Programming, Res Triangle Pk, NC 27709 USA
Fleming, JW
Edwards, MT
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Stat & Programming, Res Triangle Pk, NC 27709 USA
Edwards, MT
Moore, MA
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Stat & Programming, Res Triangle Pk, NC 27709 USA
Moore, MA
Brothers, CH
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Stat & Programming, Res Triangle Pk, NC 27709 USA
Brothers, CH
Scott, TR
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Stat & Programming, Res Triangle Pk, NC 27709 USA
Scott, TR
机构
:
[1]
GlaxoSmithKline, Stat & Programming, Res Triangle Pk, NC 27709 USA
[2]
GlaxoSmithKline, Infect Dis Med Dev Ctr HIV, Res Triangle Pk, NC 27709 USA
[3]
Tomorrow Associates Inc, Cary, NC USA
[4]
GlaxoSmithKline, Regulatory Affairs, Res Triangle Pk, NC USA
来源
:
ANNALS OF PHARMACOTHERAPY
|
2004年
/ 38卷
/ 12期
关键词
:
D O I
:
10.1345/aph.1E202
中图分类号
:
R9 [药学];
学科分类号
:
1007 ;
摘要
:
引用
收藏
页码:2171 / 2172
页数:2
相关论文
共 4 条
[1]
HERNANDEZ J, 2003, 5 INT WORKSH ADV DRU
[2]
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
Hetherington, S
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Hetherington, S
Hughes, AR
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Hughes, AR
Mosteller, M
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Mosteller, M
Shortino, D
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Shortino, D
Baker, KL
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Baker, KL
Spreen, W
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Spreen, W
Lai, E
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Lai, E
Davies, K
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Davies, K
Handley, A
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Handley, A
Dow, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Dow, DJ
Fling, ME
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Fling, ME
Stocum, M
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Stocum, M
Bowman, C
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Bowman, C
Thurmond, LM
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Thurmond, LM
Roses, AD
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Roses, AD
[J].
LANCET,
2002,
359
(9312)
: 1121
-
1122
[3]
Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir
Hetherington, S
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
Hetherington, S
McGuirk, S
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
McGuirk, S
Powell, G
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
Powell, G
Cutrell, A
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
Cutrell, A
Naderer, O
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
Naderer, O
Spreen, B
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
Spreen, B
Lafon, S
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
Lafon, S
Pearce, G
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
Pearce, G
Steel, H
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
Steel, H
[J].
CLINICAL THERAPEUTICS,
2001,
23
(10)
: 1603
-
1614
[4]
Risk factor analysis of hypersensitivity reactions to abacavir
Symonds, W
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
Symonds, W
Cutrell, A
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
Cutrell, A
Edwards, M
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
Edwards, M
Steel, H
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
Steel, H
Spreen, B
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
Spreen, B
Powell, G
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
Powell, G
McGuirk, S
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
McGuirk, S
Hetherington, S
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
Hetherington, S
[J].
CLINICAL THERAPEUTICS,
2002,
24
(04)
: 565
-
573
←
1
→
共 4 条
[1]
HERNANDEZ J, 2003, 5 INT WORKSH ADV DRU
[2]
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
Hetherington, S
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Hetherington, S
Hughes, AR
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Hughes, AR
Mosteller, M
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Mosteller, M
Shortino, D
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Shortino, D
Baker, KL
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Baker, KL
Spreen, W
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Spreen, W
Lai, E
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Lai, E
Davies, K
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Davies, K
Handley, A
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Handley, A
Dow, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Dow, DJ
Fling, ME
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Fling, ME
Stocum, M
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Stocum, M
Bowman, C
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Bowman, C
Thurmond, LM
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Thurmond, LM
Roses, AD
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA
Roses, AD
[J].
LANCET,
2002,
359
(9312)
: 1121
-
1122
[3]
Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir
Hetherington, S
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
Hetherington, S
McGuirk, S
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
McGuirk, S
Powell, G
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
Powell, G
Cutrell, A
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
Cutrell, A
Naderer, O
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
Naderer, O
Spreen, B
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
Spreen, B
Lafon, S
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
Lafon, S
Pearce, G
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
Pearce, G
Steel, H
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, HIV OI Clin Dev, Res Triangle Pk, NC 27709 USA
Steel, H
[J].
CLINICAL THERAPEUTICS,
2001,
23
(10)
: 1603
-
1614
[4]
Risk factor analysis of hypersensitivity reactions to abacavir
Symonds, W
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
Symonds, W
Cutrell, A
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
Cutrell, A
Edwards, M
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
Edwards, M
Steel, H
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
Steel, H
Spreen, B
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
Spreen, B
Powell, G
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
Powell, G
McGuirk, S
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
McGuirk, S
Hetherington, S
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Clin Dev HIV OI, Res Triangle Pk, NC 27709 USA
Hetherington, S
[J].
CLINICAL THERAPEUTICS,
2002,
24
(04)
: 565
-
573
←
1
→